Despegar.com (DESP) Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Despegar.com in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" DESP shares.
View DESP analyst ratings or view top-rated stocks.

2 equities research analysts have issued 12-month price targets for Despegar.com's shares. Their DESP share price forecasts range from $7.00 to $13.00. On average, they anticipate the company's share price to reach $9.75 in the next twelve months. This suggests a possible upside of 37.5% from the stock's current price.
View analysts price targets for DESP or view top-rated stocks among Wall Street analysts.

Despegar.com's stock was trading at $5.13 at the beginning of 2023. Since then, DESP shares have increased by 38.2% and is now trading at $7.09.
View the best growth stocks for 2023 here.

Despegar.com saw a drop in short interest in the month of August. As of August 31st, there was short interest totaling 392,000 shares, a drop of 12.0% from the August 15th total of 445,300 shares. Based on an average trading volume of 199,800 shares, the days-to-cover ratio is currently 2.0 days. Approximately 0.7% of the shares of the company are short sold.
View Despegar.com's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 16th 2023.
View our DESP earnings forecast.

Despegar.com, Corp. (NYSE:DESP) issued its quarterly earnings results on Thursday, August, 17th. The company reported $0.07 earnings per share for the quarter, beating analysts' consensus estimates of $0.05 by $0.02. The business earned $165.52 million during the quarter, compared to analysts' expectations of $160.50 million.

ETFs with the largest weight of Despegar.com (NYSE:DESP) stock in their portfolio include ETFMG Travel Tech ETF (AWAY).Global X MSCI Argentina ETF (ARGT).

Despegar.com updated its FY 2023 earnings guidance on Thursday, August, 17th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $640.00 million-$700.00 million, compared to the consensus revenue estimate of $669.48 million.

90 employees have rated Despegar.com Chief Executive Officer Damian Scokin on Glassdoor.com. Damian Scokin has an approval rating of 72% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Despegar.com investors own include Allena Pharmaceuticals (ALNA), Autolus Therapeutics (AUTL), Invesco (IVZ), Sorrento Therapeutics (SRNE), Akari Therapeutics (AKTX), Avadel Pharmaceuticals (AVDL), BorgWarner (BWA) and electroCore (ECOR).

(DESP) raised $314 million in an IPO on Wednesday, September 20th 2017. The company issued 12,800,000 shares at a price of $23.00-$26.00 per share. Morgan Stanley and Citigroup served as the underwriters for the IPO and Itau BBA, UBS Investment Bank, Cowen and KeyBanc Capital Markets were co-managers.

Despegar.com trades on the New York Stock Exchange (NYSE) under the ticker symbol "DESP."

Shares of DESP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DESP stock can currently be purchased for approximately $7.09.

Despegar.com (NYSE:DESP) has a market capitalization of $468.37 million and generates $537.97 million in revenue each year. The company earns $-68,520,000.00 in net income (profit) each year or ($0.36) on an earnings per share basis.

The company employs 4,543 workers across the globe.

Despegar.com's mailing address is JUANA MANSO 999, BUENOS AIRES C1, C1107CBR. The official website for the company is www.despegar.com.ar. The company can be reached via phone at 541148943500.